Artificial Intelligence (AI) Stocks Performance Guide: AbCellera Biologics (ABCL)
ABCL has no dividends.
Table and Chart of ABCL Performance
See what a $1,000 investment in ABCL is worth today.
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| ABCL Returns | |
|---|---|
| Start Date | Jan-29-2021 |
| Start Price | $52.83 |
| End Date | May-15-2024 |
| End Price | $3.70 |
| # Prices | 41 |
| Min Date | May-15-2024 |
| Min Price | $3.70 |
| Max Date | Jan-29-2021 |
| Max Price | $52.83 |
| Total Return | -93.00% |
| Annualized Return | -54.08% |
| Current Value of $1,000 Purchase | $70 |
| Number Returns | 820 |
| Average Return | -42.17% |
| Number Profitable Returns | 85 |
| Percent Profitable Returns | 10.37% |
| Number Unprofitable Returns | 735 |
| Percent Unprofitable Returns | 89.63% |
| Profitable to Unprofitable Returns Ratio | 0.12 |
| ABCL Data | |
|---|---|
| VALUATION DATA | |
| Market Capitalization | $1,126,227,000 |
| Beta | 0.360 | Price to Sales | 33.42 |
| Earnings per Share | $-0.5100 |
| PE Ratio | None |
| PE to Growth Ratio | None |
| Price to Book | 1.103 |
| PRICE DATA | |
| 52 Week High | $8.05 |
| 52 Week Low | $3.62 |
| Analyst Target Price | $15.25 |
| 50-Day Moving Average | $4.344 |
| 200-Day Moving Average | $4.928 |
| FINANCIAL DATA | |
| Revenue per Share | $0.131 |
| Revenue | $38,025,000 |
| Profit Margin | 0% |
| Return on Equity | -12.3% |
| Stock Dividend, Valuation, Price and Financial Data Input | |
ABCL Compare Returns with S&P 500
ABCL Trendline Chart
ABCL Moving Average Chart
ABCL Stock Return Map - See Patterns of Gains and Losses
ABCL Stock Returns/Purchase Dates